Latest filing published 16 Apr 2026 for Viatris Inc.
Corinne Le Goff discloses dealings in 2 companies, chiefly Viatris Inc and Imunon, Inc. Between 18 July 2022 and 15 April 2026, the trades on record add up to 22 filings.
No open-market purchase appears, only 1 sale worth €61k. Outside the open market, there are 11 share grants and 10 option exercises.
On 16 April 2026 came the latest disclosure, an option exercise in Viatris Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations